JP2006512335A5 - - Google Patents

Download PDF

Info

Publication number
JP2006512335A5
JP2006512335A5 JP2004558137A JP2004558137A JP2006512335A5 JP 2006512335 A5 JP2006512335 A5 JP 2006512335A5 JP 2004558137 A JP2004558137 A JP 2004558137A JP 2004558137 A JP2004558137 A JP 2004558137A JP 2006512335 A5 JP2006512335 A5 JP 2006512335A5
Authority
JP
Japan
Prior art keywords
group
carbon atoms
protected
coor
cooh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004558137A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006512335A (ja
JP4954477B2 (ja
Filing date
Publication date
Priority claimed from FR0215428A external-priority patent/FR2848210B1/fr
Application filed filed Critical
Publication of JP2006512335A publication Critical patent/JP2006512335A/ja
Publication of JP2006512335A5 publication Critical patent/JP2006512335A5/ja
Application granted granted Critical
Publication of JP4954477B2 publication Critical patent/JP4954477B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004558137A 2002-12-06 2003-11-28 新規複素環化合物、それらの調製、ならびに薬剤として、特に抗菌剤およびβ−ラクタマーゼ阻害剤としてのそれらの使用 Expired - Fee Related JP4954477B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/15428 2002-12-06
FR0215428A FR2848210B1 (fr) 2002-12-06 2002-12-06 Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
PCT/FR2003/003523 WO2004052891A1 (fr) 2002-12-06 2003-11-28 Composes heterocyclique, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases

Publications (3)

Publication Number Publication Date
JP2006512335A JP2006512335A (ja) 2006-04-13
JP2006512335A5 true JP2006512335A5 (https=) 2012-03-22
JP4954477B2 JP4954477B2 (ja) 2012-06-13

Family

ID=32320045

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004558137A Expired - Fee Related JP4954477B2 (ja) 2002-12-06 2003-11-28 新規複素環化合物、それらの調製、ならびに薬剤として、特に抗菌剤およびβ−ラクタマーゼ阻害剤としてのそれらの使用

Country Status (9)

Country Link
EP (1) EP1569935B1 (https=)
JP (1) JP4954477B2 (https=)
KR (1) KR101146802B1 (https=)
AT (1) ATE405567T1 (https=)
AU (1) AU2003294104A1 (https=)
CA (1) CA2507607C (https=)
DE (1) DE60323135D1 (https=)
FR (1) FR2848210B1 (https=)
WO (1) WO2004052891A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844273B1 (fr) 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
UA95454C2 (uk) 2005-07-15 2011-08-10 Амр Текнолоджи, Інк. Арил- і гетероарилзаміщені тетрагідробензазепіни і їх застосування для блокування зворотного захоплення норепінефрину, допаміну і серотоніну
WO2007065288A2 (en) 2005-12-07 2007-06-14 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
FR2914923B1 (fr) * 2007-04-12 2013-06-14 Novexel Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens.
FR2921060B1 (fr) 2007-09-14 2012-06-15 Novexel Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
FR2937034B1 (fr) 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
US9505761B2 (en) 2011-12-02 2016-11-29 Fedora Pharmaceuticals Inc. Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
RU2614418C2 (ru) * 2012-08-25 2017-03-28 Вокхардт Лимитед Производные 1,6-диазабицикло[3.2.1]октан-7-она и их применение для лечения бактериальных инфекций
UA111925C2 (uk) 2012-12-11 2016-06-24 Федора Фармасьютікалз Інк. БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ
WO2014141132A1 (en) * 2013-03-14 2014-09-18 Naeja Pharmaceutical Inc. NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
JP6764862B2 (ja) * 2014-11-17 2020-10-07 エンタシス・セラピューティックス・リミテッド 耐性細菌感染症の治療のための併用療法
DK3512851T3 (en) 2016-09-16 2022-10-17 Entasis Therapeutics Ltd Beta-lactamase inhibitor compounds
JOP20190061A1 (ar) 2016-09-28 2019-03-26 Novartis Ag مثبطات بيتا-لاكتاماز
WO2018208769A1 (en) 2017-05-08 2018-11-15 Entasis Therapeutics, Inc. Compounds and methods for treating bacterial infections
EP3604309A1 (en) 2018-07-30 2020-02-05 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
EP3604315A1 (en) * 2018-07-30 2020-02-05 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
CN115151544B (zh) 2020-09-01 2024-08-16 宁夏农林科学院 β-内酰胺酶抑制剂及其制备
CN115605480B (zh) 2021-05-07 2024-04-05 宁夏农林科学院 磺酰脒取代的化合物及其作为β-内酰胺酶抑制剂的用途
WO2024227071A1 (en) * 2023-04-26 2024-10-31 Entasis Therapeutics Limited Synthesis of durlobactam

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676230B1 (fr) * 1991-05-07 1993-08-27 Centre Nat Rech Scient Nouveaux derives de pyrrolo [1,4]-benzodiazepines, leur procede de preparation et medicaments les contenant.
CZ282567B6 (cs) * 1993-12-29 1997-08-13 Pfizer Inc. Diazabicyklické sloučeniny a farmaceutické prostředky na jejich bázi
DE19627431A1 (de) * 1996-07-08 1998-01-15 Bayer Ag Heterocyclisch kondensierte Pyridine
EP1091944A1 (en) * 1998-06-30 2001-04-18 Du Pont Pharmaceuticals Company 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
CO5180550A1 (es) * 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) * 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases

Similar Documents

Publication Publication Date Title
JP2006512335A5 (https=)
JP2002528550A5 (https=)
JPH01113382A (ja) フェノール性チアン誘導体およびカラー写真記録材料の安定剤としてのそれらの使用方法
JP2002543183A5 (https=)
JP2020536881A5 (https=)
JP2010528089A5 (https=)
JP2002529532A5 (https=)
JP2004537541A5 (https=)
JP2005526076A5 (https=)
JP2005510476A5 (https=)
JP2003503387A5 (https=)
JP2009515872A5 (https=)
WO2005113537B1 (en) Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
JP2005530709A5 (https=)
JP2006522035A5 (https=)
JP2005529956A5 (https=)
JP2009503114A5 (https=)
JP2005523310A5 (https=)
JP2008510828A5 (https=)
JP2019515643A5 (https=)
JP2009524691A5 (https=)
JP2006528621A5 (https=)
JP2003525286A5 (https=)
JP2005517643A5 (https=)
JP2001514171A5 (https=)